Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Mar 25, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Risk Stratification in Differentiated Thyroid Cancer: An Ongoing Process.

Gal Omry-Orbach¹

¹Department of Endocrinology, Diabetes and Metabolism, Virginia Mason Medical Center, Seattle, WA, USA.

Rambam Maimonides Medical Journal

|February 18, 2016

Summary

This summary is machine-generated.

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same journal

Why Is PaO<sub>2</sub> Not Enough? Arterial Oxygen Content as a Prognostic Indicator in COPD Patients.

Rambam Maimonides medical journal·2026

Same journal

Relationship Between Visual Perception and Participation Performance in Children with Autism Spectrum Disorder Aged 4-6 Years: A Cross-Sectional Study.

Rambam Maimonides medical journal·2026

Same journal

IgG4-related Mastitis: An Underrecognized Diagnosis in Breast Core Biopsies.

Rambam Maimonides medical journal·2026

Same journal

Deprescribing: Reducing Harm, Enhancing Care.

Rambam Maimonides medical journal·2026

Same journal

Mifepristone: Reflections on its Early Clinical Development for Medical Abortion.

Rambam Maimonides medical journal·2026

Same journal

Jewish Contributions to Plastic and Reconstructive Surgery.

Rambam Maimonides medical journal·2026

Thyroid cancer is rising globally, necessitating accurate risk stratification beyond initial staging. This helps tailor treatment and monitoring to individual patient needs, improving outcomes and reducing unnecessary interventions.

Area of Science:

Endocrinology
Oncology
Surgical Oncology

Background:

Thyroid cancer prevalence is increasing worldwide, posing significant social and economic challenges.
While mortality is low, up to 30% of differentiated thyroid cancer patients face recurrence, necessitating precise risk assessment.
Current staging systems predict mortality but inadequately assess recurrence risk, leading to suboptimal patient management.

Purpose of the Study:

To review the evolving process of risk stratification in differentiated thyroid cancer.
To highlight key concepts and emerging trends in assessing recurrence risk.
To discuss the potential of pre-operative risk stratification to guide treatment decisions.

Main Methods:

Review of current literature on thyroid cancer risk stratification.

More Related Videos

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

Related Experiment Videos

Last Updated: Mar 25, 2026

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma

Published on: June 2, 2023

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Author Spotlight: Integrating Ultrasound Imaging with Biochemical Markers for Thyroid Disease Diagnosis

Published on: February 9, 2024

Analysis of traditional histopathologic staging (AJCC/UICC) and its limitations.

Exploration of dynamic, response-to-therapy assessments and novel markers (biochemical, genetic, molecular).

Main Results:

Risk stratification for differentiated thyroid cancer is a dynamic, ongoing process.
Traditional staging is insufficient for predicting recurrence; additional variables are crucial.
Incorporation of biochemical, genetic, and molecular markers refines risk assessment.
Pre-operative risk stratification is emerging as a valuable tool.

Conclusions:

Accurate, continuous risk stratification is essential for personalized management of differentiated thyroid cancer.
Risk-adaptive management improves patient outcomes by tailoring monitoring and treatment.
Emerging pre-operative stratification tools may help balance treatment risks and benefits.